We are part of the CSL Limited group of companies. See how we're Driven by Our Promise.
We collaborate with rare disease organizations to promote quality medical care and services.
We offer a variety of support programs and activities for the patients we serve.
We also aim to make sure that nothing holds you back from getting the therapies you need.
Our product portfolio focuses on innovation in new products, improved products and manufacturing expertise.
A clinical trial is a research study that is done to find out if medical treatments can improve people’s health.
We work every day as if someone’s life depends on it, because it does.
We manufacture products to treat a number of rare diseases.
Help us deliver on our promise to save lives and protect the health of people.
Diversity and inclusion are top priorities for CSL Behring.
5 Reasons Why Diversity Matters in Clinical Trials
Broadening access to clinical trials is better for science and patients.
Research Aimed at the Sickest COVID-19 Patients
Dr. William Zhang receives the American Thoracic Society/CSL Behring Research Award to study Acute Respiratory Distress Syndr…
Together, Let's Move at the Speed of Science
A condensed version of my address to academia, governments and industry during the Times Higher Education Health and Wellbein…
Listen: The Safety of Vaccines
Gregg Sylvester, Chief Medical Officer and Head of Medical Affairs for Seqirus, discusses vaccine safety on new episode of Wo…
Biotech Firms Respond to IP Debate
Hundreds of CEOs sign a joint statement, saying IP “created the biotech network that responded so quickly to the COVID crisis…
Listen: How Technology Is Changing Vaccines
On a new episode of World of Promise, an R&D leader discusses vaccine innovation, including aQIVc and self-amplifying mRNA.
Video: Bringing the Patient Perspective to Work
One CSL Behring employee’s experience as a clinical trial participant now informs her work to help fellow patients.
"Flu Will Return, Make No Doubt About It"
See what Beverly Taylor, a leader at one of the world’s largest flu vaccine providers, Seqirus, said about the upcoming flu s…
A Reckoning With Pain
Sickle cell patient and community advocate, Kyle Smith, describes the physical and emotional impact of a disease too long in …
A Letter of Thanks
On Clinical Trials Day, employees acknowledge those who take part in research.
CSL Behring's New R&D Campus in Germany
Video: “Topping-out” milestone celebrated in Marburg for facility scheduled to open in 2022.
Finding Empowerment in R&D
Two of our leaders in research talked to Biospace about the culture at work. “It’s easy to be brave at CSL. There is that sup…
Popular search terms:
Americas
Asia Pacific
Europe
This website uses cookies to improve user experience. By continuing to use this website, you consent to our use of these cookies. To learn more about how we use and manage cookies, see our Privacy Policy and Cookie Policy.
